Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Remote Interventions From Pharmacists Shown to Improve Blood Glucose Control for Type 2 Diabetes - about 1 month ago FDA Grants Breakthrough Device Designation for System Maintaining Weight Loss After GLP-1 - 3 months ago Teva Launches Generic Formulation of Liraglutide in US - 4 months ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - 6 months ago FLOW Trial Results Demonstrate Positive Kidney Outcomes With Semaglutide - 8 months ago Investigational GLP-1 Medication Found to Reduce Body Weight - 8 months ago Proposed Biosimilar Liraglutide Shows Non-Inferiority to Reference Drug for Type 2 Diabetes - 10 months ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - 11 months ago
2	Elaine Chen STAT News Reporter at STATnews. Formerly at Business Insider. Chicago, Illinois journalism	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - about 1 month ago Parkinson’s disease may be helped by GLP-1 drug, new study finds - 7 months ago STAT+: Liver disease MASH is next target for obesity drugs in development - 8 months ago STAT+: Wegovy may have another helpful trick: fighting inflammation via the brain, study finds - 10 months ago
3	Allison DeAngelis STAT News Reporter at STAT. Formerly Insider, BBJ. biopharmastartupsventure capital	STAT+: Can amylin drugs best Wegovy and Zepbound? Companies bet on next big obesity target - about 1 month ago
4	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Reporter Cell Line Development and Optimization for High Throughput Screening  - 2 months ago
5	Kristen Monaco MedPage Today	Early-Stage GLP-1 Win in Obesity; An Argument for BMI's Value; Insulin Supply Issues - 3 months ago Popular Diabetes Drug Class Lowered Risk of 10 Obesity-Associated Cancers - 3 months ago Insulin Out-of-Stock; Yet Another GLP/GIP Agonist; Digital Diabetes Tools Worth It? - 7 months ago Glucose Changes in Type 1 Diabetes May Affect Thinking Speed - 7 months ago Amy Schumer's Cushing's Dx; One Billion People With Obesity; Vitamin D for T1D - 8 months ago One Class of Antidiabetic Linked With Lower Kidney Stone Risk - 9 months ago Breast Cancer Drug Repurposed for Infant With Congenital Hyperinsulinism - 9 months ago Study Assuages Fears of Pancreatic Cancer Risk With GLP-1 Receptor Agonists - 10 months ago In Acute Kidney Disease, SGLT2 inhibitors Were All-Around Protective - 10 months ago JAK Inhibitor Preserves Beta-Cell Function in Early Type 1 Diabetes - 11 months ago Phase II Wins, Losses for Obesity Drugs; More Positive Veozah Data; Walking Off T2D - 11 months ago Mounjaro vs Ozempic for Obesity; New Microwave Ablation System; GAHT Erythrocytosis - 11 months ago Glucose Supplement Recalled; ADA Sued by Former Employee; Forteo Generic OK'd - 11 months ago Tirzepatide Wins FDA Approval for Weight Loss - 11 months ago Farxiga Cuts A1c in Pediatric Diabetes; Late-Stage CAH Win; At-Home Menopause Test - about 1 year ago Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Risk - about 1 year ago FDA Approves Another SGLT2 Inhibitor for Treating CKD - about 1 year ago
6	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think - 3 months ago
7	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Boehringer Ingelheim’s survodutide shows promise in liver fibrosis treatment - 4 months ago
8	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Study Finds Semaglutide Improves Chronic Kidney Disease in Patients With Type 2 Diabetes - 5 months ago
9	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	Diabetes Drug Shows Benefit in Parkinson's Disease - 7 months ago Can a GLP-1 Agonist Improve Parkinson's Symptoms? - 10 months ago
10	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	To penetrate crowded GLP-1 field, Rivus Pharma is taking a metabolic approach - 7 months ago

Journalists covering glucokinase